Story · Medicine & Biotech · Mind & Brain
Marco Donia: TIL Therapy Without Systemic IL-2 in Melanoma
1 outlet · first reported by OncoDaily on
Marco Donia, Professor of Clinical Oncology at University of Copenhagen, shared on LinkedIn: “TIL therapy without systematic IL-2: a step toward more accessible cell therapy” High-dose IL-2 made TIL therapy (OncoDaily)
Coverage, in order
-
Marco Donia: TIL Therapy Without Systemic IL-2 in MelanomaMarco Donia, Professor of Clinical Oncology at University of Copenhagen, shared on LinkedIn: “TIL therapy without systematic IL-2: a step toward more accessible cell therapy” High-dose IL-2 made TIL therapy
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.